rs10497327

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020981.4(B3GALT1):​c.-352+13339G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0587 in 152,074 control chromosomes in the GnomAD database, including 561 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.059 ( 561 hom., cov: 32)

Consequence

B3GALT1
NM_020981.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0270
Variant links:
Genes affected
B3GALT1 (HGNC:916): (beta-1,3-galactosyltransferase 1) This gene is a member of the beta-1,3-galactosyltransferase (beta3GalT) gene family. This family encodes type II membrane-bound glycoproteins with diverse enzymatic functions using different donor substrates (UDP-galactose and UDP-N-acetylglucosamine) and different acceptor sugars (N-acetylglucosamine, galactose, N-acetylgalactosamine). The beta3GalT genes are distantly related to the Drosophila Brainiac gene and have the protein coding sequence contained in a single exon. The beta3GalT proteins also contain conserved sequences not found in the beta4GalT or alpha3GalT proteins. The carbohydrate chains synthesized by these enzymes are designated as type 1, whereas beta4GalT enzymes synthesize type 2 carbohydrate chains. The ratio of type 1:type 2 chains changes during embryogenesis. By sequence similarity, the beta3GalT genes fall into at least two groups: beta3GalT4 and 4 other beta3GalT genes (beta3GalT1-3, beta3GalT5). This gene is expressed exclusively in the brain. The encoded protein shows strict donor substrate specificity for UDP-galactose. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
B3GALT1NM_020981.4 linkuse as main transcriptc.-352+13339G>A intron_variant ENST00000392690.4
B3GALT1XM_011512085.3 linkuse as main transcriptc.-368+13339G>A intron_variant
B3GALT1XM_047446159.1 linkuse as main transcriptc.-352+13339G>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
B3GALT1ENST00000392690.4 linkuse as main transcriptc.-352+13339G>A intron_variant NM_020981.4 P1

Frequencies

GnomAD3 genomes
AF:
0.0586
AC:
8904
AN:
151956
Hom.:
558
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0863
Gnomad ASJ
AF:
0.0193
Gnomad EAS
AF:
0.0998
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.00509
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.00699
Gnomad OTH
AF:
0.0489
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0587
AC:
8928
AN:
152074
Hom.:
561
Cov.:
32
AF XY:
0.0593
AC XY:
4406
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.142
Gnomad4 AMR
AF:
0.0863
Gnomad4 ASJ
AF:
0.0193
Gnomad4 EAS
AF:
0.0995
Gnomad4 SAS
AF:
0.0999
Gnomad4 FIN
AF:
0.00509
Gnomad4 NFE
AF:
0.00699
Gnomad4 OTH
AF:
0.0546
Alfa
AF:
0.0125
Hom.:
11
Bravo
AF:
0.0679
Asia WGS
AF:
0.135
AC:
468
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
11
DANN
Benign
0.70

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10497327; hg19: chr2-168516815; API